– UK, Bottisham – Cambridge Cognition Holdings plc (LON: COG), which develops and markets digital solutions to assess brain health, announced the appointments of Stuart Gall and Nick Rodgers to its Board as independent non-executive Directors effective from 1 February 2024.
About Stuart Gall
Stuart Gall is CEO of Intelligent Ultrasound, an AIM-listed medical imaging company providing one of the world’s leading ‘classroom to clinic’ ultrasound technologies. Previous appointments include joint founder and executive director of Fusion IP plc, an AIM-listed university IP commercialization company, before its purchase by IP Group plc for £103 million in 2014. Stuart has over 30 years of experience in both small company start-ups and public companies and previously worked at British Airways plc, The Promotions Partnership Limited, Anvil Limited, and Toad plc.
About Philip Rodgers (“Nick”)
Nick Rodgers is currently Chair of SEHTA, one of the largest health technology membership and networking organizations in the UK supporting businesses in the health technology sector. Until 2023 Nick was Chair of Destiny Pharma plc, a developer of novel anti-infective products, and chair of ZPN Energy Limited, a developer of battery storage technologies and systems for the electric vehicle market. Previously, until 2016, Nick was chairman of Oxford BioMedica plc, a pioneer of gene and cell therapy, and a leader in lentiviral vector research, development, and bioprocessing.
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to understand, detect, and treat conditions affecting brain health. The Company’s software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and improve global efficiency in the pharmaceutical and healthcare industries.
For more information: https://cambridgecognition.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
